Eam Investors, LLC Cti Biopharma Corp Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $1.99 Million - $2.76 Million	-371,173 Reduced 44.1%	470,576 $2.74 Million
Q2 2022 Aug 12, 2022	SELL	$3.55 - $6.27 $604,160 - $1.07 Million	-170,186 Reduced 16.82%	841,749 $5.03 Million
Q1 2022 May 13, 2022	BUY	$1.9 - $5.23 $1.92 Million - $5.29 Million	1,011,935 New	1,011,935 $4.73 Million
Q1 2021 May 11, 2021	SELL	$2.68 - $3.8 $643,489 - $912,410	-240,108 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$2.48 - $3.8 $595,467 - $912,410	240,108 New	240,108 $773,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.